Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A 172 | IC50 | 8.3 μM | Antiproliferative activity against human A 172 cells measured after 7 days by CCK8 assay | [PMID: 32248003] |
| HEK-293T | EC50 | 0.9 μM | Partial agonist activity at recombinant human GAL4-DBD-fused LXRbeta-LBD expressed in HEK293T cells measured after 12 to 14 hrs by dual-glo luciferase reporter gene assay | [PMID: 28169169] |
| HEK-293T | EC50 | 1.44 μM | Partial agonist activity at recombinant human GAL4-DBD-fused LXRalpha-LBD expressed in HEK293T cells measured after 12 to 14 hrs by dual-glo luciferase reporter gene assay | [PMID: 28169169] |
| Huh-7 | EC50 | 3.67 μM | Agonist activity at human LXRbeta ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay | [PMID: 19962892] |
| Huh-7 | EC50 | 3.67 μM | Agonist activity at human recombinant LXRbeta ligand binding domain in human HuH7 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18973288] |
| Huh-7 | EC50 | 6.66 μM | Agonist activity at human LXRalpha ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay | [PMID: 19962892] |
| Huh-7 | EC50 | 6.66 μM | Agonist activity at human recombinant LXRalpha ligand binding domain in human HuH7 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18973288] |
| U-251 | IC50 | 3.06 μM | Antiproliferative activity against human U-251 cells measured after 7 days by CCK8 assay | [PMID: 32248003] |
| U-87MG ATCC | IC50 | 6.14 μM | Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay | [PMID: 32248003] |
9 records · Scroll to view more